ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.920
+0.020 (0.51%)
Feb 11, 2026, 4:00 PM EST - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $485.6 million as of February 12, 2026. Its market cap has increased by 198.94% in one year.
Market Cap
485.60M
Enterprise Value
708.30M
1-Year Change
198.94%
Ranking
Category
Stock Price
$3.92
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $485.60M, a decrease of -76.23%. That is a compound annual growth rate of -22.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 483.12M | 10.48% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 517.25M |
| Lexeo Therapeutics | 513.83M |
| Neumora Therapeutics | 508.12M |
| Lyell Immunopharma | 503.69M |
| Zevra Therapeutics | 484.72M |
| Verastem | 484.70M |
| Prothena Corporation | 482.32M |
| Zura Bio | 474.50M |